8 results on '"Ianculescu N"'
Search Results
2. Performance of 18F-FDG PET/CT in the diagnosis of endocarditis
- Author
-
Desgranges, F, primary, Kamani, C, additional, Rotzinger, D, additional, Guery, B, additional, Ianculescu, N, additional, Auberson, D, additional, Tzimas, G, additional, Hugelshofer, S, additional, Tozzi, P, additional, Kirsch, M, additional, Monney, P, additional, Prior, J, additional, and Papadimitriou-Olivgeris, M, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Predictors of persistent fever among patients with suspected infective endocarditis: think outside the box.
- Author
-
Stavropoulou E, Monney P, Tzimas G, Ianculescu N, Tozzi P, Kirsch M, Guery B, and Papadimitriou-Olivgeris M
- Abstract
Background: Fever is common in infective endocarditis (IE), yet little is known about fever duration in such patients. We aim to identify predictors of persistent fever in patients with suspected IE., Methods: This study was conducted at the Lausanne University Hospital, Switzerland, from January 2014 to June 2023. All patients with suspected IE being febrile upon presentation were included. Fever (>38°C) was considered persistent if it continued for at least 96h from antimicrobial treatment initiation. A case was classified as IE by the Endocarditis Team., Results: Among 1399 episodes with suspected IE, persistent fever was observed in 260 (19%) episodes. IE was diagnosed in 536 (41%) episodes, of which 82 (15%) had persistent fever. Among episodes with suspected IE, persistent bacteremia/candidemia for 96h (P<0.001), spondylodiscitis (P=0.039), intrabdominal infection (P=0.001) were associated with persistent fever. Conversely, bacteremia by streptococci (P=0.049), or enterococci (P=0.001), source control performed withing 96h (P=0.015) and appropriate antimicrobial treatment within 48h (P=0.018) were associated with early defervescence. No association between persistent fever and infective endocarditis was found (P=0.207). Among 536 IE episodes, persistent bacteremia/candidemia for 96h (P<0.001), and native bone and joint infection (P=0.020) were associated with persistent fever. Conversely, bacteremia by streptococci or enterococci (P=0.001; aOR 0.25, 95% CI 0.11-0.58) were associated with early defervescence., Conclusions: In episodes with suspected IE, persistent fever was associated with spondylodiscitis, inappropriate antimicrobial treatment and absence of source control interventions. Among IE patients, persistent fever was associated with native bone and joint infections., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
4. Impact of multidisciplinary Endocarditis Team on management of infective endocarditis.
- Author
-
Fourré N, Zimmermann V, Guery B, Ianculescu N, Tozzi P, Kirsch M, Monney P, and Papadimitriou-Olivgeris M
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Positron Emission Tomography Computed Tomography, Anti-Bacterial Agents therapeutic use, Treatment Outcome, Endocarditis mortality, Patient Care Team
- Abstract
Infective Endocarditis (IE) is a complex, life-threatening disease. The aim of the present study was to evaluate the impact of the Endocarditis-Team on management of IE. This observational study conducted at a university hospital (2015‒22), included adult patients with IE. The study period was divided in two periods: before (pre-Endocarditis-Team; pre-ET) and after the establishment of the Endocarditis-Team (post-Endocarditis-Team; post-ET) on January 2018. Among 505 IE episodes (187 in pre-Endocarditis-Team, 318 in post-ET period),
18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography was more commonly used in post-ET period (14 % vs. 28 %; p < 0.001). Overall, thirty-day and one-year mortality were 14 % and 27 %, respectively; no difference was observed between the two periods. In post-ET period, the administration of 4-weeks, rather than 6-weeks, of intravenous antimicrobial treatment was higher than in the post-ET period (15 % vs. 45 %; p < 0.001). Indication for surgery was present in 115 (61 %) patients in pre-ET and in 153 (48 %) in the post-ET period. In post-ET period, among patients with indication, valve surgery was more frequently performed (66 % vs. 78 %; p = 0.038). Such difference was due to a higher acceptance of operative indication by the cardiac surgeon (69 % vs. 94 %; p = 0.013). The observed increase in number of patients benefiting from cardiac surgery in the post-ET period led to a decrease of subsequent embolic events, since among patients with operative indication (n = 268), new embolic events after the establishment of the indication were more common in the pre-ET period compared to post-ET (23 % vs. 12 %; p = 0.033). After the implementation of the multidisciplinary Endocarditis-Team we observed several improvements in the general management of IE patients., Competing Interests: Conflicts of interest The authors declare no conflicts of interest., (Copyright © 2024 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
5. Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis.
- Author
-
Papadimitriou-Olivgeris M, Guery B, Ianculescu N, Auberson D, Tozzi P, Kirsch M, and Monney P
- Subjects
- Humans, Staphylococcus aureus, Prospective Studies, Abscess complications, Risk Factors, Anti-Bacterial Agents therapeutic use, Endocarditis, Bacterial diagnosis, Endocarditis drug therapy, Endocarditis complications, Embolism etiology, Embolism complications, Sepsis drug therapy
- Abstract
Purpose: Embolic events (EEs) are a common complication of left-side infective endocarditis (IE). The aim of the present study was to identify risk factors for the occurrence of EEs before or after antibiotic treatment instauration among patients with definite or possible IE., Methods: This retro-prospective study was conducted at the Lausanne University Hospital, Lausanne, Switzerland, from January 2014 to June 2022. EEs and IE were defined according to modified Duke criteria., Results: A total of 441 left-side IE episodes were included (334: 76% were definite and 107; 24% possible IE). EE were diagnosed in 260 (59%) episodes; in 190 (43%) before antibiotic treatment initiation and 148 (34%) after. Central nervous system (184; 42%) was the most common site of EE. Multivariable analysis identified S. aureus (P 0.022), immunological phenomena (P < 0.001), sepsis (P 0.027), vegetation size ≥ 10 mm (P 0.003) and intracardiac abscess (P 0.022) as predictors of EEs before antibiotic treatment initiation. For EEs after antibiotic treatment initiation, multivariable analysis revealed vegetation size ≥ 10 mm (P < 0.001), intracardiac abscess (P 0.035) and prior EE (P 0.042), as independent predictors of EEs, while valve surgery (P < 0.001) was associated with lower risk for EEs., Conclusions: We reported a high percentage of EEs among patients with left-side IE; vegetation size, intracardiac abscess, S. aureus and sepsis were independently associated with the occurrence of EEs. In addition to antibiotic treatment, early surgery led to further decrease in EEs incidence., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
6. Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis.
- Author
-
Papadimitriou-Olivgeris M, Monney P, Rotzinger DC, Kamani CH, Fahrni G, Prior JO, Ianculescu N, Messaoudi Y, Tozzi P, Kirsch M, and Guery B
- Subjects
- Humans, Positron Emission Tomography Computed Tomography adverse effects, Positron Emission Tomography Computed Tomography methods, Fluorodeoxyglucose F18, Tomography, X-Ray Computed adverse effects, Tomography, X-Ray Computed methods, Radiopharmaceuticals, Endocarditis, Bacterial complications, Endocarditis complications, Endocarditis diagnostic imaging, Endocarditis therapy
- Abstract
Background: Embolic events (EEs) are a common complication of infective endocarditis (IE) and their presence can impact diagnosis and modify the therapeutic plan. The present study aimed to describe the role of thoracoabdominal imaging, either thoracoabdominal-pelvic Computed Tomography or
18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, on diagnosis and management of patients with suspected IE., Methods: This study was conducted at a university hospital, from January 2014 to June 2022. EEs and IE were defined according to modified Duke criteria., Results: Among 966 episodes with suspected IE and thoracoabdominal imaging, 528 (55%) patients were asymptomatic. At least one EE was found in 205 (21%) episodes. Based on thoracoabdominal imaging findings, the diagnosis was reclassified from rejected to possible or from possible to definite IE in 6 (1%) and 10 (1%) episodes, respectively. Among the 413 patients with IE, at least one EE was found on thoracoabdominal imaging in 143 (35%) episodes. Together with the presence of left-side valvular vegetation >10 mm, the results of thoracoabdominal imaging established a surgical indication (prevention of embolism) in 15 (4%) episodes, 7 of which were asymptomatic., Conclusions: Thoracoabdominal imaging performed in asymptomatic patients with suspected IE improved the diagnosis in only a small proportion of patients. Thoracoabdominal imaging led to a new surgical indication (in association with left-side valvular vegetation >10 mm) in only a small percentage of patients., Competing Interests: Declaration of Competing Interest The authors declare there is no conflict of interests., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
7. Role of Cerebral Imaging on Diagnosis and Management in Patients With Suspected Infective Endocarditis.
- Author
-
Papadimitriou-Olivgeris M, Guery B, Ianculescu N, Dunet V, Messaoudi Y, Pistocchi S, Tozzi P, Kirsch M, and Monney P
- Subjects
- Humans, Switzerland, Endocarditis diagnostic imaging, Endocarditis, Bacterial diagnostic imaging, Endocarditis, Bacterial therapy
- Abstract
Background: Cerebral embolic events (CEEs) are common complications of infective endocarditis (IE), and their presence can modify diagnosis and therapeutic plans. The aim of the present study was to assess the role of cerebral imaging (Cer-Im) on diagnosis and management of patients with suspected IE., Methods: This study was conducted at the Lausanne University Hospital, Lausanne, Switzerland, from January 2014 to June 2022. CEEs and IE were defined according to modified Duke criteria of the European Society of Cardiology (ESC) guidelines., Results: Among 573 patients with IE suspicion and Cer-Im, 239 (42%) patients had neurological symptoms. At least 1 CEE was found in 254 (44%) episodes. Based on Cer-Im findings, episodes were reclassified from rejected to possible or from possible to definite IE in 3 (1%) and 25 (4%) patients, respectively (0% and 2% in asymptomatic patients, respectively). Among the 330 patients with possible or definite IE, at least 1 CEE was found in 187 (57%) episodes. A new surgical indication (in association with left-side vegetation >10 mm) was established in 74/330 (22%) IE patients and 30/155 (19%) asymptomatic IE patients, respectively., Conclusions: Cer-Im in asymptomatic patients with IE suspicion showed limited potential for improving the diagnosis of IE. In contrast, performing Cer-Im in asymptomatic patients with IE may be useful for decision making, because Cer-Im findings led to the establishment of new operative indication for valvular surgery in one fifth of patients according to ESC guidelines., Competing Interests: Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2023
- Full Text
- View/download PDF
8. The role of early defervescence in ruling out infective endocarditis: a cohort study.
- Author
-
Stavropoulou E, Guery B, Ianculescu N, Tozzi P, Kirsch M, Monney P, and Papadimitriou-Olivgeris M
- Subjects
- Humans, Cohort Studies, Echocardiography, Transesophageal, Anti-Bacterial Agents therapeutic use, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial drug therapy, Endocarditis, Bacterial microbiology, Endocarditis diagnosis, Endocarditis drug therapy
- Abstract
Objectives: To evaluate the role of defervescence within 4 days from antibiotic treatment initiation in ruling out infective endocarditis (IE) among patients suspected of such diagnosis., Methods: This study was conducted at the Lausanne University Hospital, Switzerland (January 2014 to May 2022). All patients with suspected IE being febrile upon presentation were included. IE was classified according to the modified Duke criteria proposed by the 2015 European Society of Cardiology guidelines, before or after applying the criterion 'resolution of symptoms suggesting IE within 4 days of the introduction of antibiotic therapy' based solely on early defervescence., Results: Among 1022 episodes with suspected IE, 332 (37%) had IE according to Endocarditis-Team evaluation; 248 were classified by clinical Duke criteria as definite and 84 as possible IE. The rate of defervescence within 4 days from antibiotic treatment initiation was similar (p 0.547) among episodes without (606/690; 88%) and those with IE (287/332; 86%); among episodes classified as definite and possible IE by clinical Duke criteria, 211 of 248 (85%) and 76 of 84 (90%), respectively, defervesced within 4 days from antibiotic treatment initiation. By using early defervescence as a rejection criterion, the 76 episodes with final IE diagnosis classified as possible by clinical criteria could be reclassified as rejected., Discussion: The majority of IE episodes defervesced within 4 days from antibiotic treatment initiation; thus, early defervescence should not be used to rule out the diagnosis of IE., (Copyright © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.